Erythroderma: Review of a potentially life -threatening dermatosis

Indian Journal of Dermatology

Volumn 54, Issue 1, 2009, Pages 1-6

  Okoduwa, Cynthia ^a   Lambert, W C ^a   Schwartz, R A ^a   Kubeyinje, E ^a   Eitokpah, A ^a   Sinha, Smeeta ^a   Chen, W ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

African patients; Causes; Erythroderma

Indexed keywords

ANTIMALARIAL AGENT; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; LITHIUM; PADGEM PROTEIN; STEROID; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CASE REPORT; CLINICAL FEATURE; CUTANEOUS T CELL LYMPHOMA; DISEASE COURSE; DRUG INDUCED DISEASE; ECZEMA; EOSINOPHILIA; ERYTHRODERMA; FEMALE; HISTOPATHOLOGY; HUMAN; INCIDENCE; MALE; NEGRO; PATHOGENESIS; PHOTODERMATOSIS; PHYSICAL EXAMINATION; PROGNOSIS; PSORIASIS; REVIEW; RISK FACTOR; SEX RATIO; SEZARY CELL; SEZARY SYNDROME; SKIN CARE;

EID: 64349110303     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.48976     Document Type: Review

References (64)

1. Busia K. Medical provision in Africa. Phyother Res 2005;19: 919-23.
2. Ferrante P, Delbue, S., Mancuso, R. The manifestation of AIDS in Africa: An epidemiological overview. J Neurovirol 2005;11:50-7.
3. Sehgal VN, Srivastava G. Exfoliative dermatitis: A prospective study of 80 patients. Dermatologica 1986;173:278-84.
4. Sigurdsson V, Steegmans PH, van Vloten WA. The incidence of erythroderma: A survey among all dermatologists in The Netherlands. J Am Acad Dermatol 2001;45:675-8.
5. Rym BM, Mourad M, Bechir Z Dalenda E, Faika C, Iadh AM, et al. Erythroderma in adults: A report of 80 cases. Int J Dermatol 2005;44:731-5.
6. Rothe MJ, Bialy TL, Grant-Kels JM. Erythroderma. Dermatol Clin 2000;18:405-15.
7. Balasubramaniam P, Berth-Jones J. Erythroderma:90% skin failure. Hosp Med 2004;65:100-2.
8. Akhyani M, Ghodsi ZS, Toosi S, Dabbaghian H. Erythroderma: A clinical study of 97 cases. BMC Dermatol 2005;5:5.
9. Botella-Estrada R, Sanmartin O, Oliver V, Febrer I, Aliaga A. Erythroderma: A clinicopathological study of 56 cases. Arch Dermatol 1994;130:1503-7.
10. Hasan T, Jansen CT. Erythroderma: A follow-up of fifty cases. J Am Acad Dermatol 1983;8:836-40.
11. Leenutaphong V, Kulthanan K, Pohboon C, Suthipinittharn P, Sivayathorn A, Sunthonpalin P. Erythroderma in Thai patients. J Med Assoc Thailand 1999;82:743-8.
12. Pal S, Haroon TS. Erythroderma: A clinico-etiologic study of 90 cases. Int J Dermatol 1998;37:104-7.
13. Sigurdsson V, Toonstra J, Hezemans-Boer M, van Vloten WA. Erythroderma: A clinical and follow-up study of 102 patients, with special emphasis on survival. J Am Acad Dermatol 1996;35:53-7.
14. Rubins AY, Hartmane IV, Lielbriedis YM, Schwartz RA. Therapeutic options for erythroderma. Cutis 1992;49:424-6.
15. Breathnach SM. Management of drug eruptions: Part II, Diagnosis and treatment. Australas J Dermatol 1995;36:187-91.
16. Karakayli G, Beckham G, Orengo I, Rosen T. Exfoliative dermatitis. Am Fam Physician 1999;59:625-30.
17. Guin JD, Phillips D. Erythroderma from systemic contact dermatitis: A complication of systemic gentamicin in a patient with contact allergy to neomycin. Cutis 1989;43:564-7.
18. Cockayne S, Gawkrodger D, McDonagh A. Severe erythrodermic reactions to the proton pump inhibitors omperazole and lansoprazole. Br J Dermatol 1999;141:173-4.
19. Morar N, Dlova N, Gupta AK, Naidoo DK, Aboobaker J, Ramdial PK. Erythroderma: A comparison between HIV positive and negative patients. Int J Dermatol 1999;38:895-900.
20. Chakraborty. Lymphoma as a cause of exfoliative dermatitis. Indian J Dermatol 1983;28:121-3.
21. Nishijima S. Papuloerythroderma associated with hepatocellular carcinoma. Br J Dermatol 1998;139:1115-6.
22. Axelrod JH, Herbold DR, Freel JH, Palmer SM. Exfoliative dermatitis: Presenting sign of fallopian tube carcinoma. Obstet Gynecol 1988;71:1045-7.
23. Deffer TA, Overton-Keary PP, Goette DK. Erythroderma secondary to esophageal carcinoma. J Am Acad Dermatol 1985;13:311-3.
24. Harper TG, Latuska RF, Sperling HV. An unusual association between erythroderma and an occult gastric carcinoma. Am J Gastroenterol 1984;79:921-3.
25. Kameyama H, Shirai Y, Date K, Kuwabara A, Kurosaki R, Hatakeyama K. Gallbladder carcinoma presenting as exfoliative dermatitis (erythroderma). Int J Gastrointest Cancer 2005;35:153-5.
26. Nousari HC, Kimyai-Asadi A, Spegman DJ. Paraneoplastic dermatomyositis presenting as erythroderma. J Am Acad Dermatol 1998;39:653-4.
27. Patrizi A, Pileri S, Rivano MT, Di Lernia V. Malignant histiocytosis presenting as erythroderma. Int J Dermatol 1990;29:214-6.
28. Rosen T, Chappell R, Drucker C. Exfoliative dermatitis: Presenting sign of internal malignancy. Southern Med J 1979;72:652-3.
29. Bittencourt AL, Barbosa H, Brites C, Ferraz N. Clinicopathological aspects of HTLV-1 positive and negative T-cell lymphoma. Eur J Dermatol 1997;7:283-9.
30. vonderheid EC, Bernengo MG, Burg G. Update on erythroderma cutaneous T-cell lymphoma-Report of International Society for Cutaneous Lymphoma. J Am Acad Dermatol 2002;46:95-106.
31. Burns MK, Cooper KD. Cutaneous T-cell lymphoma associated with HIV infection. J Am Acad Dermatol 1993;29:394-9.
32. Higgins EM, du Vivier AW. Cutaneous manifestations of malignant disease. Br J Hosp Med 1992;48:552-4.
33. Vonderheid EC. On the diagnosis of erythrodermic cutaneous T-cell lymphoma. J Cutan Pathol 2006;33:27-42.
34. Vonderheid EC, Bernengo MG. The Sezary syndrome:hematologic criteria. Hematol Oncol Clin North Am 2003;17:1367-89.
35. Abel EA, Lindae ML, Hoppe RT, Wood GS. Benign and malignant forms of erythroderma: Cutaneous immunophenotypic characteristics. J Am Acad Dermatol 1988;19:1089-95.
36. Fujiwara E, Tado O, Sasaki H, Hayashi Y. An autopsy case of postoperative erythroderma after nephroureterectomy possibly induced by graft-versus-host reaction following blood transfusion. Nippon Hinyokika Gakkai Zasshi - Jpn J Urol 1992;83:348-51.
37. Gupta R, Khera V. Erythroderma due to dermatophyte. Acta Dermatol Venereol 2000.
38. Janniger CK, Gascon P, Schwartz RA, Hennessey NP, Lambert WC. Erythroderma as the initial presentation of the acquired immunodeficiency syndrome. Dermatologica 1991;183:143-5.
39. Mutasim DF. Severe subacute cutaneous lupus erythematosus presenting with generalized erythroderma and bullae. J Am Acad Dermatol 2003;48:947-9.
40. Nazzari G, Crovato F, Nigro A. Papuloerythroderma (Ofuji): Two additional cases and review of the literature. J Am Acad Dermatol 1992;26:499-501.
41. Otsuka S, Kunieda K, Hirose M, Takeuchi H, Mizutani Y, Nagaya M, et al. Fatal erythroderma (suspected graft-versushost disease) after cholecystectomy: Retrospective analysis. Transfusion 1989;29:544-8.
42. Pierson JC, Taylor JS. Erythrodermic dermatomyositis. J Am Acad Dermatol 1993;28:136.
43. Schwartz RA, Leevy CM, Cohen PJ, Lambert WC. Erythroderma with fulminant hepatitis: A possible association. Cutis 1986;37:56-8.
44. Takedai T, Yamamoto I, Tokeshi J. Acute generalized pustular psoriasis presenting with erythroderma associated with shock and acute renal failure. Hawaii Med J 2003;62:278-81.
45. Yungmann MP, Ford MJ. Histoplasmosis presenting as erythroderma in a patient with the acquired immunodeficiency syndrome. Int J Dermatol 2003;42:636-9.
46. Zemtsov A, Elks M, Shehata B. Thyrotoxicosis presenting as generalized pruritic exfoliative dermatitis and fever. Dermatology 1992;184:157.
47. Yoon C, Lee C. Clinicopathological cases. Clin Exp Dermatol 2003;28:575-6.
48. Sigurdsson V, de Vries IJ, Toonstra J, Bihari IC, Thepen T, Bruijnzeel-Koomen CA, et al. Expression of VCAM-1, ICAM-1, E-selectin, and P-selectin on endothelium in situ in patients with erythroderma, mycosis fungoides and atopic dermatitis. J Cutan Pathol 2000;27:436-40.
49. Wilson DC, Jester JD, King LE, Jr. Erythroderma and exfoliative dermatitis. Clin Dermatol 1993;11:67-72.
50. Sehgal VN, Srivastava G, Sardana K. Erythroderma/exfoliative dermatitis: A synopsis. Int J Dermatol 2004;43:39-47.
51. Sigurdsson V, Toonstra J, Bihari IC. Interleukin-4 and interferongamma expression of the dermal infiltrate in patients with erythroderm and mycosis fungoides- an immunohistochemical study. J Cutan Pathol 2000;27:436-40.
52. Freedberg IM. Exfoliative Dermatitis. In:Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw Hill; 2003. p. 1-17.
53. Kanwar AJ, Dhar S, Ghosh S. 'Nose sign' in dermatology. Dermatology 1993;187:278.
54. Agarwal S, Khullar R, Kalla G, Malhotra YK. Nose sign of exfoliative dermatitis: A possible mechanism. Arch Dermatol 1992;128:704.
55. Jaffer AN, Brodell RT. Exfoliative dermatitis: Erythroderma can be a sign of a significant underlying disorder. Postgrad Med 2005;117:49-51.
56. Shelley WB, Shelley ED. Shoreline nails: Sign of drug-induced erythroderma. Cutis 1985;35:220-2.
57. Joly P, Tanasescu S, Wolkenstein P, Bocquet H, Gilbert D. Lichenoid erythrodermic bullous pemphigoid of the African patient. J Am Acad Dermatol 1998;39:691-7.
58. Harris DW, Spencer MJ, Tidman MJ. Papuloerythroderma- -clinical and ultrastructural features. Clin Exp Dermatol 1990;15:105-6.
59. Ofuji S. Papuloerythroderma. J Am Acad Dermatol 1990;22:697.
60. Lacour JP, Perrin C, Ortonne JP. Ofuji papuloerythroderma: A new European case. Dermatology 1993;186:190-2.
61. Nicolis GD, Helwig EB. Exfoliative dermatitis: A clinicopathologic study of 135 cases. Arch Dermatol 1973;108:788-97.
62. Sigurdsson V, Toonstra J, van Vloten WA. Idiopathic erythroderma: A follow-up study of 28 patients. Dermatology 1997;194:98-101.
63. Rothe MJ, Bernstein ML, Grant-Kels JM. Life-threatening erythroderma: Diagnosing and treating the "red man". Clin Dermatol 2005;23:206-17.
64. Mutluer S, Yerebakan O, Alpsoy E, Ciftcioglu MA, Yilmaz E. Treatment of papuloerythroderma of Ofuji with Re-PUVA: A case report and review of the therapy. J Eur Acad Dermatol Venereol 2004;18:480-3.